Navigation Links
Cedars-Sinai heart transplantation tip sheet
Date:4/24/2010

LOS ANGELES (April 21 2010) Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. The presentations will take place April 21 24 in Chicago during the 30th Annual Scientific Meeting of the International Society of Heart and Lung Transplantation.

"The International Society for Heart and Lung Transplantation Scientific Sessions bring together the world's experts in these fields which also includes basic science and mechanical circulatory assist devices," said Jon Kobashigawa, M.D., director of the Cedars-Sinai Heart Institute heart transplant program. "This important dialogue and exchange of valuable information will lead to improved survival and quality of life of our patients."

An associate director of the Cedars-Sinai Heart Institute, Kobashigawa is a past president of the International Society for Heart and Lung Transplantation. His research has resulted in groundbreaking medical protocols, such as customized anti-rejection medications for transplant patients.

Cedars-Sinai Heart Institute researchers will make more than 30 presentations during the meeting, including:

  • A review of 520 first-time heart transplant patients showed no significant difference survival rates based on age. Although patients 70 or older were more likely to have coronary artery disease and prior coronary bypass surgery, 10-year survival rates were equal to younger transplant patients. Older patients did have lower rates of diabetes mellitus, hypertension, obesity and smoking compared to the younger patients. Embargo lifts 8 a.m. CDT April 21.

  • Transplant patients who receive hearts from organ donors who were homeless are at increased risk for complications and poor outcomes. Although homelessness is not included in the Centers for Disease Control criteria for high-risk organ donation, half the patients who received hearts from homeless organ donors died within the first year of transplantation. Researchers believe that homelessness leads to poor hygiene and increased susceptibility to infections, which can affect organ recipients. Further study is needed to confirm whether homelessness should be added to the high-risk organ donation category. Embargo lifts 9:50 a.m. CDT April 22, 2020.

  • Patients who smoked prior to receiving a heart transplant experienced worse outcomes than patients who never smoked. Following transplant, 10 percent of patients who formerly smoked experienced non-fatal, major adverse cardiac events, such as a stroke or heart failure, compared to just 4 percent of transplant patients who never smoked. Embargo lifts 3 p.m. CDT April 22.

  • After reviewing 10-year survival and outcomes of 574 transplant patients, researchers found no difference in outcome for patients who received a heart from a donor of a different race. Embargo lifts noon CDT, April 23.

  • Transplant patients who receive donor hearts from the opposite gender typically have worse outcomes than patients who receive a heart from the same gender. Males who received hearts from males had a 69 percent survival rate 10 years after transplant, compared to 59 percent 10 year survival rate for males who received hearts from females. Females who received hearts from females had a 71 percent survival rate, compared to 58 percent for females who received hearts from males. Embargo lifts 2:30 p.m. CDT April 24.


'/>"/>

Contact: Sally Stewart
sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
2. Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms
3. Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting
4. Research team led by Cedars-Sinai identifies genes linked to ulcerative colitis
5. New strategies to improve treatment and avert heart failure in children
6. Added Sugars in Diet Threaten Heart Health
7. Blood test identifies people at risk for heart attack that other tests miss
8. Device Avoids Open-Heart Surgery When Artificial Valve Fails
9. Abnormal Heart Rhythm Linked to Alzheimers
10. HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart
11. B-vitamins Help Protect Against Stroke, Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: